China vs South-East Asia (WHO region): Confirmed cases of RR-/MDR-TB
China
15,255
in 2024
South-East Asia (WHO region)
61,774
in 2024
China rank
3rd
South-East Asia (WHO region) rank
3rd
Confirmed cases of RR-/MDR-TB over time
- China
- South-East Asia (WHO region)
How they compare
South-East Asia (WHO region) currently reports 61,774 against 15,255 in China, a difference of 46,519.
That makes South-East Asia (WHO region)'s figure about 4.0 times China's.
Across all 18 years both countries report, South-East Asia (WHO region) has been ahead every year.
China ranks 3rd and South-East Asia (WHO region) ranks 3rd of 195 countries.
South-East Asia (WHO region) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 185 | 1,421 | 1,236 | South-East Asia (WHO region) |
| 2010s | 8,487 | 35,578 | 27,092 | South-East Asia (WHO region) |
| 2020s | 15,147 | 65,136 | 49,988 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of rr-/mdr-tb, China or South-East Asia (WHO region)?
- South-East Asia (WHO region), at 61,774 against 15,255 in China as of 2024.
- What is the difference in confirmed cases of rr-/mdr-tb between China and South-East Asia (WHO region)?
- 46,519, with South-East Asia (WHO region) ahead.
- How many years of comparable data are there for China and South-East Asia (WHO region)?
- 18 years are reported by both, from 2006 to 2024.
- How do China and South-East Asia (WHO region) rank globally for confirmed cases of rr-/mdr-tb?
- China ranks 3rd and South-East Asia (WHO region) ranks 3rd of 195 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of RR-/MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.